ATTERX BIOTHERAPEUTICS
Atterx is developing fundamentally new therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical crisis, globally responsible for hundreds of thousands of deaths each year. ConjuGon's core technology is a new way to kill unwanted and even multi-drug resistant bacteria. The company is located in the MG&E Innovation Center in the University Research Park in Madison, Wisconsin.
ATTERX BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2001-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.atterx.com
Total Employee:
1+
Status:
Active
Contact:
6084412891
Total Funding:
6.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Content Delivery Network COVID-19 Wix Wix Media
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
AkaRx
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
H. Thomas Watkins Director @ Atterx Biotherapeutics
Director
Richard Burgess Co-Founder @ Atterx Biotherapeutics
Co-Founder
2001-04-01
Steven Watt CEO @ Atterx Biotherapeutics
CEO
Founder
Investors List
Michigan Rise
Michigan Rise investment in Series C - Atterx Biotherapeutics
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Rosetta Partners
Rosetta Partners investment in Venture Round - Atterx Biotherapeutics
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Official Site Inspections
http://www.atterx.com Semrush global rank: 8.98 M Semrush visits lastest month: 445
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Atterx Biotherapeutics"
About | Atterx Biotherapeutics
Atterx has an IND on file with the FDA and is poised to enter a combined Phase I/II clinical trial. GN-4474 uses the natural process of bacterial conjugation to prevent and treat infections …See details»
Leadership | Atterx Biotherapeutics
Dr. Dorsey joined Atterx in 2008. He received a B.S. in Molecular Biology and Biochemistry from the University of Wisconsin-Eau Claire. and a Ph.D. in Microbiology with a Molecular Biology emphasis from Miami University. He …See details»
Atterx Biotherapeutics - Crunchbase Company Profile …
Atterx is developing fundamentally new therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical …See details»
Atterx Biotherapeutics, Inc. Company Profile | Madison, WI ...
Find company research, competitor information, contact details & financial data for Atterx Biotherapeutics, Inc. of Madison, WI. Get the latest business insights from Dun & Bradstreet.See details»
Atterx Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Atterx Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Technology Platform ...See details»
Atterx Biotherapeutics Company Profile 2024: …
Atterx Biotherapeutics General Information Description. Developer of antibacterial-resistant products designed to provide treatment for bacterial infections. The company's products prevent catheter-associated urinary tract …See details»
Atterx Biotherapeutics - Overview, News & Similar companies
View Atterx Biotherapeutics (www.atterx.com) location in Wisconsin, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Atterx Biotherapeutics - Company Profile - Tracxn
Nov 29, 2024 Atterx (formerly known as Conjugon) has developed two products to fight multi-drug resistant, Gram-negative bacteria. Their first product, C-1205 utilizes bacterial …See details»
Atterx Biotherapeutics Company Profile -Sales, Contacts, …
Atterx Biotherapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 23 years. The Most Advanced Company Information Database ...See details»
Atterex Biotherapeutics, Inc - University Research Park
Oct 30, 2024 Atterx Biotherapeutics, Inc is a R&D/Clinical stage biotechnology company that is developing novel therapies for the prevention and treatment of bacterial infections. Our lead …See details»
December 2024 Member Spotlight: Atterx - Exchange Home
Join NIAMRRE as we highlight Atterx during the Member Spotlight on December 3, 2025, noon-1pm CT. The presentation will provide an overview Atterx's novel solutions currently in …See details»
Atterx Biotherapeutics - Contacts, Employees, Board Members, …
Atterx develops therapeutics to fight the growing epidemic of antibiotic resistant bacteria.See details»
Richard Burgess - Co-Founder @ Atterx Biotherapeutics
Primary Organization . Atterx Biotherapeutics . Location Madison, Wisconsin, United States; ... Dr. Burgess is a co-founder of Atterx. He is a fellow of both the American Association for the Advancement of Science and the American Academy of Microbiology and was a founding director of the University of Wisconsin Biotechnology Center. Dr ...See details»
Atterx BioTherapeutics - Craft
Atterx BioTherapeutics is a company developing products that prevent and treat antibiotic-resistant bacterial infections. It offers C-1205, a drug that utilizes bacterial interference …See details»
Leadership | Atterx Biotherapeutics
Dr. Watt has been with Atterx since 2006. Previous to joining Atterx, he held senior management positions as Director of Cell Biology & Transgenesis at Infigen, Inc. and as Director of …See details»
Atterx Biotherapeutics - Funding, Financials, Valuation & Investors
Atterx Biotherapeutics is funded by 3 investors. Michigan Rise and Wisconsin Investment Partners are the most recent investors. Atterx Biotherapeutics has a post-money valuation in the range …See details»
What is Atterx BioTherapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Atterx BioTherapeutics. Salaries, reviews, and more - all posted by employees working at Atterx BioTherapeutics.See details»
Working at Atterx BioTherapeutics - Glassdoor
Work at Atterx BioTherapeutics? Share your experiences. Atterx BioTherapeutics. Select a star to rate. Start your review. Add salary Add interview Add benefits. Glassdoor gives you an inside …See details»
Research programme: antibacterial wound infection therapies - Atterx …
The US-based biotechnology company, Atterx Biotherapeutics(formerly ConjuGon), is using its proprietary broad-platform technology to develop biotherapeutics Research programme: antibacterial wound infection therapies - Atterx Biotherapeutics - AdisInsightSee details»